Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
A2-ESO-1 TCR-Engineered T Cells for Relapsed/Refractory Advanced or Metastatic NY-ESO-1 Overexpression Positive Triple Negative Breast Cancer
Apply
A2-ESO-1 TCR-T Cells
A2-ESO-1 TCR-Engineered T Cells for Relapsed/Refractory Advanced or Metastatic NY-ESO-1 Overexpression Positive Triple Negative Breast Cancer
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step